Her2 overexpression is associated with an increased subpopulation of cancer stem cells and correlates with activation of the PI3K/AKT pathway, leading to increased expression of stem cell markers Oct3/4, Notch1, Notch2, Jagged1 and Gli1 [27]. This evidence concerns the gene ERBB2 and cancer.